FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282983019> ?p ?o ?g. }

• W4282983019 endingPage "2598" @default.
• W4282983019 startingPage "2598" @default.
• W4282983019 abstract "Abstract The ATM inhibitor AZD1390 disrupts cellular responses to ionizing radiation (IR) and is a potent radiosensitizer being tested in clinical trials. Here, we evaluated, the effects of AZD1390 on radiation sensitivity and DNA damage repair pathways in glioblastoma (GBM) cells and patient derived xenografts (PDXs). AZD1390 (30 nM and higher) suppressed IR (5 Gy)-induced phosphorylation of ATM-Serine1981 and downstream phosphorylation sites on Kap1, Chk2 and H2AX in U251 cells and multiple PDXs. Consistent with enhanced DNA damage, AZD1390 increased IR induced G2/M arrest in U251 (80.6% with AZD1390/IR vs. 64.6% with IR, p= 0.01), GBM43 (61.9% vs. 25.7%, p= 0.01) and GBM39 (40.9% vs. 25.4%, p= 0.01). Moreover, in a clonogenic survival assay, AZD1390 sensitized U251 cells to 5 Gy IR (0.24% survival with AZD1390/IR vs. 2.3% with IR alone, p=0.01). In a reporter-based analysis of DNA repair capacity, ATM inhibition resulted in a 40 to 60% reduction in homologous recombination (HR) and modest but significant decrease in micro-homology mediated end joining (MMEJ) and gap fill-in synthesis in U251 cells but had no effect on non-homologous end joining, translesion synthesis, nucleotide or base excision repair pathways. Comparing effects of AZD1390 on repair in GBM14 (TP53-wt) and GBM43 (TP53-mutant), similar results were observed except that decreased MMEJ was seen only in GBM43 (0.03± 0.01% vs. 0.07± 0.01% in control, p=0.002). Intriguingly, RAD51 knockdown (to disrupt HR) sensitized U251 and GBM43 but not GBM14. The efficacy of AZD1390 ± IR was studied in vivo in 10 PDXs. IR was delivered to orthotopic tumors using opposed lateral 225 kVp beams. AZD1390 (20 mg/kg PO) was given just prior to each radiation dose (2 Gy x 5 fractions). AZD1390 monotherapy was mostly ineffective, IR alone was reasonably efficacious with an average 1.8 ± 0.1-fold-increase in survival relative to sham radiation (survival ratio) across all 10 models. IR/AZD1390 treatment resulted in significant survival extension relative to IR alone in 6 of 10 models. Analysis of the survival benefit of combination therapy compared to IR alone across the entire cohort of PDXs was statistically marginal (average survival ratio 2.3± 0.3 vs. 1.8 ± 0.1 with IR, p=0.08). However, when stratified by TP53 status, combination therapy was significantly more effective than IR (mean survival ratio 2.3 ± 0.1 vs. 1.6 ± 0.2 with IR alone, p=0.02) in TP53-mutant PDXs, where all 5 models benefited. In contrast, TP53-wt group had no benefit (mean survival ratio 2.2 ± 0.5 vs. 2.0 ± 0.2, p=0.61), GBM39 was only TP53-wt PDX that benefited from the combination. In conclusion, AZD1390 is an effective radio-sensitizer that causes disruption in HR and potentially other DNA repair pathways. Interestingly, in vivo radiosensitizing effects are mostly restricted to TP53-mutant GBM PDXs. Understandingmechanism of resistance in the context of different TP53 backgrounds remains an important future direction. Citation Format: Shiv K. Gupta, Jiajia Chen, Daniel J. Laverty, Surabhi Talele, Brett L. Carlson, Ann C. Mladek Tuma, Danielle Burgenske, Gaspar J. Kitange, Petra Hamerlik, Zachary D. Nagel, Stephen T. Durant, William F. Elmquist, Jann N. Sarkaria. AZD1390 radio-sensitizes p53-mutant GBM via disrupting homology directed DNA repair [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 2598." @default.
• W4282983019 created "2022-06-17" @default.
• W4282983019 creator A5006614002 @default.
• W4282983019 creator A5015247761 @default.
• W4282983019 creator A5019792014 @default.
• W4282983019 creator A5029721184 @default.
• W4282983019 creator A5032385628 @default.
• W4282983019 creator A5037781231 @default.
• W4282983019 creator A5040880361 @default.
• W4282983019 creator A5042944026 @default.
• W4282983019 creator A5044853707 @default.
• W4282983019 creator A5050483295 @default.
• W4282983019 creator A5052198607 @default.
• W4282983019 creator A5075781493 @default.
• W4282983019 creator A5086178089 @default.
• W4282983019 date "2022-06-15" @default.
• W4282983019 modified "2023-10-14" @default.
• W4282983019 title "Abstract 2598: AZD1390 radio-sensitizes p53-mutant GBM via disrupting homology directed DNA repair" @default.
• W4282983019 doi "https://doi.org/10.1158/1538-7445.am2022-2598" @default.
• W4282983019 hasPublicationYear "2022" @default.
• W4282983019 type Work @default.
• W4282983019 citedByCount "0" @default.
• W4282983019 crossrefType "journal-article" @default.
• W4282983019 hasAuthorship W4282983019A5006614002 @default.
• W4282983019 hasAuthorship W4282983019A5015247761 @default.
• W4282983019 hasAuthorship W4282983019A5019792014 @default.
• W4282983019 hasAuthorship W4282983019A5029721184 @default.
• W4282983019 hasAuthorship W4282983019A5032385628 @default.
• W4282983019 hasAuthorship W4282983019A5037781231 @default.
• W4282983019 hasAuthorship W4282983019A5040880361 @default.
• W4282983019 hasAuthorship W4282983019A5042944026 @default.
• W4282983019 hasAuthorship W4282983019A5044853707 @default.
• W4282983019 hasAuthorship W4282983019A5050483295 @default.
• W4282983019 hasAuthorship W4282983019A5052198607 @default.
• W4282983019 hasAuthorship W4282983019A5075781493 @default.
• W4282983019 hasAuthorship W4282983019A5086178089 @default.
• W4282983019 hasConcept C102744134 @default.
• W4282983019 hasConcept C104451858 @default.
• W4282983019 hasConcept C117262875 @default.
• W4282983019 hasConcept C11960822 @default.
• W4282983019 hasConcept C126322002 @default.
• W4282983019 hasConcept C134935766 @default.
• W4282983019 hasConcept C143425029 @default.
• W4282983019 hasConcept C145803527 @default.
• W4282983019 hasConcept C153911025 @default.
• W4282983019 hasConcept C172512520 @default.
• W4282983019 hasConcept C185592680 @default.
• W4282983019 hasConcept C187206112 @default.
• W4282983019 hasConcept C190283241 @default.
• W4282983019 hasConcept C2776428644 @default.
• W4282983019 hasConcept C2779012473 @default.
• W4282983019 hasConcept C502942594 @default.
• W4282983019 hasConcept C509974204 @default.
• W4282983019 hasConcept C54355233 @default.
• W4282983019 hasConcept C552990157 @default.
• W4282983019 hasConcept C62478195 @default.
• W4282983019 hasConcept C71924100 @default.
• W4282983019 hasConcept C74054111 @default.
• W4282983019 hasConcept C86803240 @default.
• W4282983019 hasConcept C95444343 @default.
• W4282983019 hasConceptScore W4282983019C102744134 @default.
• W4282983019 hasConceptScore W4282983019C104451858 @default.
• W4282983019 hasConceptScore W4282983019C117262875 @default.
• W4282983019 hasConceptScore W4282983019C11960822 @default.
• W4282983019 hasConceptScore W4282983019C126322002 @default.
• W4282983019 hasConceptScore W4282983019C134935766 @default.
• W4282983019 hasConceptScore W4282983019C143425029 @default.
• W4282983019 hasConceptScore W4282983019C145803527 @default.
• W4282983019 hasConceptScore W4282983019C153911025 @default.
• W4282983019 hasConceptScore W4282983019C172512520 @default.
• W4282983019 hasConceptScore W4282983019C185592680 @default.
• W4282983019 hasConceptScore W4282983019C187206112 @default.
• W4282983019 hasConceptScore W4282983019C190283241 @default.
• W4282983019 hasConceptScore W4282983019C2776428644 @default.
• W4282983019 hasConceptScore W4282983019C2779012473 @default.
• W4282983019 hasConceptScore W4282983019C502942594 @default.
• W4282983019 hasConceptScore W4282983019C509974204 @default.
• W4282983019 hasConceptScore W4282983019C54355233 @default.
• W4282983019 hasConceptScore W4282983019C552990157 @default.
• W4282983019 hasConceptScore W4282983019C62478195 @default.
• W4282983019 hasConceptScore W4282983019C71924100 @default.
• W4282983019 hasConceptScore W4282983019C74054111 @default.
• W4282983019 hasConceptScore W4282983019C86803240 @default.
• W4282983019 hasConceptScore W4282983019C95444343 @default.
• W4282983019 hasIssue "12_Supplement" @default.
• W4282983019 hasLocation W42829830191 @default.
• W4282983019 hasOpenAccess W4282983019 @default.
• W4282983019 hasPrimaryLocation W42829830191 @default.
• W4282983019 hasRelatedWork W175612644 @default.
• W4282983019 hasRelatedWork W1964129430 @default.
• W4282983019 hasRelatedWork W2044385625 @default.
• W4282983019 hasRelatedWork W2181849395 @default.
• W4282983019 hasRelatedWork W2401497319 @default.
• W4282983019 hasRelatedWork W2775365400 @default.
• W4282983019 hasRelatedWork W2985550165 @default.
• W4282983019 hasRelatedWork W3172297981 @default.
• W4282983019 hasRelatedWork W4225393415 @default.
• W4282983019 hasRelatedWork W4282983019 @default.

• next